Top Story

Septal occluder safe, effective in transcather atrial septal defect closure

September 14, 2017

At 2-year follow-up, a septal occluder device was deemed safe and effective for transcatheter closure of atrial septal defects, according to new data published in Circulation: Cardiovascular Interventions.

The ASD PMS II study is the largest prospective trial to report the hemodynamic compromise rate and medium-term survive data on patients after septal occluder device (Amplatzer Septal Occluder [ASO], St. Jude Medical) implantation, according to researchers.

In the JournalsPerspective

Three new studies show benefit of PFO closure on reduced risk for recurrent stroke

September 13, 2017
New data from the CLOSE, REDUCE and RESPECT trials demonstrated a lower rate of recurrent ischemic stroke after patent foramen ovale closure compared with antiplatelet…

Enrollment begins for study of transcatheter tricuspid valve repair system

September 10, 2017
Abbott announced the first patient has been enrolled in a study of a minimally invasive clip-based repair system for treating people with moderate or severe tricuspid…
In the Journals

Balloon aortic valvuloplasty safe, effective in treating congenital aortic stenosis

September 7, 2017
Balloon aortic valvuloplasty for treatment of congenital aortic stenosis was associated with low rates of mortality and adverse events, according to data published in…
More Headlines »
The Take Home

The Take Home: C3

Cardiology Today's Intervention, September/October 2015
The 11th annual Complex Cardiovascular Catheter Therapeutics (C3) Advanced Endovascular and Coronary Intervention…
More »
Meeting News Coverage

VIDEO: Athena Poppas, MD, highlights late-breaking research developments in intervention

April 6, 2015
More »
Resource Centers
FDA News

FDA designates recall of catheters as Class I

June 22, 2017
The FDA has designated Vascular Solutions’ product recall of a line of catheters as a Class I recall, the most…
More »